San Diego, California–(Newsfile Corp. – December 1, 2025) – Direct Communication Solutions, Inc. (CSE: DCSI) (FSE: 7QU0) (“DCS” or the “Company”). Description of the Share Restructuring Transaction and its Material Terms: The Company is undertaking a share capital restructuring (the “Restructuring“) in which its existing shares of common stock will be redesignated as class A shares (“Class […]
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi
https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS” or “ADSs”) of WPP plc (NYSE: WPP) between February 27, 2025 and July 8, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline. So what: If you purchased WPP plc ADSsduring
(NASDAQ:TLX), NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the “Class Period”), of the important January 9, 2026 lead plaintiff deadline in the securities
NEW YORK CITY, NY / ACCESS Newswire / December 1, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Primo Brands Corporation ("Primo Brands" or the "Company") (NYSE:PRMB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail
NEW YORK CITY, NY / ACCESS Newswire / December 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of BellRing Brands, Inc. ("BellRing" or the "Company") (NYSE:BRBR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether BellRing and certain of its officers and/or
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX GlobeNewswire December 01, 2025 NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals
(All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario–(Newsfile Corp. – December 1, 2025) – Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) (OTCQX: TORXF) is pleased to provide results from the 2025 drilling program at Media Luna West, which support the Company’s strategy to target near-mine opportunities in the Media
NEW YORK CITY, NY / ACCESS Newswire / December 1, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Synopsys, Inc. ("Synopsys" or the "Company") (NASDAQ:SNPS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / December 1, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Baxter International, Inc. ("Baxter" or the "Company") (NYSE:BAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are